Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours - A prognostic test after surgical resection

Trp53 Haploinsufficiency Modifies EGFR-Driven Peripheral Nerve Sheath Tumorigenesis

(2014) Eric P. Rahrmann et al.   AMERICAN JOURNAL OF PATHOLOGY

Proliferating cell unclear antigen-associated factor (PAF15): A novel oncogene

(2014) Chanlu Xie et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies

(2014) Thomas De Raedt et al.   NATURE

Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors

(2014) Ming Zhang et al.   NATURE GENETICS

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors

(2014) William Lee et al.   NATURE GENETICS

Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients

(2013) MOULDY SIOUD et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor

(2013) Xiaoling Du et al.   Journal of Hematology & Oncology

Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors

(2013) Jacqueline D Peacock et al.   Journal of Translational Medicine

Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis

(2013) Eric P Rahrmann et al.   NATURE GENETICS

EGFR–STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors

(2013) J Wu et al.   ONCOGENE

Survivin Expression and Prognostic Significance in Pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST)

(2013) Rita Alaggio et al.   PLoS One

Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors

(2012) M. P. Ghadimi et al.   CLINICAL CANCER RESEARCH

Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target

(2012) A. V. Patel et al.   CLINICAL CANCER RESEARCH

Use of TK-cells in haploidentical hematopoietic stem cell transplantation

(2012) Giacomo Oliveira et al.   CURRENT OPINION IN HEMATOLOGY

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1

(2012) M. Kolberg et al.   NEURO-ONCOLOGY

Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms

(2011) Steven L. Carroll   ACTA NEUROPATHOLOGICA

Thymidine kinase and cancer monitoring

(2011) Stefan Aufderklamm et al.   CANCER LETTERS

Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment

(2011) J. Yang et al.   CLINICAL CANCER RESEARCH

Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor

(2011) J. Yu et al.   CLINICAL CANCER RESEARCH

Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group

(2010) Helge R. Brekke et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome

(2009) Changye Zou et al.   ANNALS OF SURGERY

Survivin: A new target for anti-cancer therapy

(2009) Bríd M. Ryan et al.   CANCER TREATMENT REVIEWS

Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways

(2009) Daniela Katz et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Expression and significance of EGFR in malignant peripheral nerve sheath tumor

(2009) Daniel Keizman et al.   JOURNAL OF NEURO-ONCOLOGY

TP53Mutation Analysis of Malignant Peripheral Nerve Sheath Tumors

(2009) Robert M. Verdijk et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors

(2009) Helge R. Brekke et al.   NEURO-ONCOLOGY

Germline and somaticNF1mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours

(2008) Irene Bottillo et al.   JOURNAL OF PATHOLOGY

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH

(2008) Stine H Kresse et al.   Molecular Cancer

EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy

(2008) Nikola Holtkamp et al.   NEURO-ONCOLOGY

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

(2008) Da Wei Huang et al.   NUCLEIC ACIDS RESEARCH